EE05506B1 - Ravimi manustamise vahend eriti progestiinide ja”strogeenide manustamiseks - Google Patents

Ravimi manustamise vahend eriti progestiinide ja”strogeenide manustamiseks

Info

Publication number
EE05506B1
EE05506B1 EEP200100256A EEP200100256A EE05506B1 EE 05506 B1 EE05506 B1 EE 05506B1 EE P200100256 A EEP200100256 A EE P200100256A EE P200100256 A EEP200100256 A EE P200100256A EE 05506 B1 EE05506 B1 EE 05506B1
Authority
EE
Estonia
Prior art keywords
strogens
progestins
administration
delivery device
drug delivery
Prior art date
Application number
EEP200100256A
Other languages
English (en)
Estonian (et)
Inventor
Tommi@Markkula
Juha@Ala@Sorvari
Harri@Jukarainen
Matti@Lehtinen
Jarkko@Ruohonen
Original Assignee
Leiras@Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras@Oy filed Critical Leiras@Oy
Publication of EE200100256A publication Critical patent/EE200100256A/xx
Publication of EE05506B1 publication Critical patent/EE05506B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200100256A 1998-11-12 1999-10-26 Ravimi manustamise vahend eriti progestiinide ja”strogeenide manustamiseks EE05506B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/190,606 US6063395A (en) 1998-11-12 1998-11-12 Drug delivery device especially for the delivery of progestins and estrogens
PCT/FI1999/000887 WO2000028968A1 (en) 1998-11-12 1999-10-26 Drug delivery device, especially for the delivery of progestins and estrogens

Publications (2)

Publication Number Publication Date
EE200100256A EE200100256A (et) 2002-12-16
EE05506B1 true EE05506B1 (et) 2012-02-15

Family

ID=22702031

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100256A EE05506B1 (et) 1998-11-12 1999-10-26 Ravimi manustamise vahend eriti progestiinide ja”strogeenide manustamiseks

Country Status (30)

Country Link
US (1) US6063395A (pt)
EP (1) EP1128811B1 (pt)
JP (1) JP2002529493A (pt)
KR (1) KR100621426B1 (pt)
CN (1) CN1168439C (pt)
AR (1) AR021152A1 (pt)
AT (1) ATE267004T1 (pt)
AU (1) AU760302B2 (pt)
BG (1) BG65042B1 (pt)
BR (1) BR9915326B1 (pt)
CA (1) CA2351068C (pt)
CO (1) CO5271704A1 (pt)
CZ (1) CZ301609B6 (pt)
DE (1) DE69917477T2 (pt)
DK (1) DK1128811T3 (pt)
EE (1) EE05506B1 (pt)
ES (1) ES2221454T3 (pt)
HK (1) HK1041814B (pt)
HU (1) HU226113B1 (pt)
ID (1) ID29190A (pt)
IL (2) IL142523A0 (pt)
NO (1) NO332168B1 (pt)
NZ (1) NZ511216A (pt)
PE (1) PE20001041A1 (pt)
PL (1) PL194876B1 (pt)
PT (1) PT1128811E (pt)
RU (1) RU2226387C2 (pt)
SK (1) SK286730B6 (pt)
WO (1) WO2000028968A1 (pt)
ZA (1) ZA200103298B (pt)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476079B1 (en) * 1999-12-23 2002-11-05 Leiras Oy Devices for the delivery of drugs having antiprogestinic properties
WO2001072663A2 (en) * 2000-03-24 2001-10-04 Lyles Mark B High density porous materials
US20060110424A1 (en) * 2000-03-24 2006-05-25 Lyles Mark B Ceramic and metal compositions
WO2001085132A1 (en) * 2000-05-10 2001-11-15 Leiras Oy Drug delivery device, especially for the delivery of levonorgestrel
US6299894B1 (en) 2000-05-10 2001-10-09 Leiras Oy Drug delivery device, especially for the delivery of gestodene
US20050101517A1 (en) * 2000-08-23 2005-05-12 Henrick De Nijs Novel testosterone ester formulation for human use
WO2002032433A1 (en) * 2000-10-20 2002-04-25 Leiras Oy Drug delivery system
US20040247674A1 (en) * 2001-08-31 2004-12-09 Timo Haapakumpu Drug delivery system
ES2388731T5 (es) * 2002-03-27 2018-01-19 Warner Chilcott (Ireland) Limited Dispositivos de administración de fármacos mediante una matriz intravaginal
AU2003301669B2 (en) * 2002-10-22 2009-04-30 Biomerix Corporation Method and system for intravesicular delivery of the therapeutic agents
EP1438942A1 (en) * 2003-01-17 2004-07-21 Schering Oy An otorhinological drug delivery device
WO2004103208A2 (en) 2003-05-15 2004-12-02 Biomerix Corporation Manufacture and use of implantable reticulated elastomeric matrices
US7763077B2 (en) 2003-12-24 2010-07-27 Biomerix Corporation Repair of spinal annular defects and annulo-nucleoplasty regeneration
CA2575988C (en) 2004-08-04 2014-02-18 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
US7862552B2 (en) * 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
KR101377900B1 (ko) * 2005-10-13 2014-03-27 신세스 게엠바하 약물-함침 용기
WO2009029958A2 (en) * 2007-08-30 2009-03-05 Sunstorm Research Corporation Implantable delivery device
PT2062569E (pt) * 2007-11-22 2011-07-25 Bayer Oy Sistema de administração vaginal
TW200927141A (en) * 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
WO2009085952A1 (en) 2007-12-20 2009-07-09 Brookwood Pharmaceuticals, Inc. Process for preparing microparticles having a low residual solvent volume
DK2359807T3 (en) 2008-02-04 2017-10-16 Ferring Bv Monolithic vaginal rings comprising progesterone and methods of preparation and use thereof
US10028858B2 (en) 2011-07-11 2018-07-24 Medicines360 Intrauterine systems, IUD insertion devices, and related methods and kits therefor
TWI590843B (zh) 2011-12-28 2017-07-11 信迪思有限公司 膜及其製造方法
US10188426B2 (en) 2013-02-06 2019-01-29 Mark SILLENDER Embryo transfer catheter and method
WO2014121332A1 (en) 2013-02-06 2014-08-14 Sillender Mark Therapeutic substance transfer catheter and method
KR102249720B1 (ko) 2013-06-21 2021-05-11 디퍼이 신테스 프로덕츠, 인코포레이티드 필름 및 제조 방법
CA2985717A1 (en) * 2015-05-13 2016-11-17 Bayer Oy A long acting drug delivery device and its use in contraception
GB2555373A (en) * 2016-08-23 2018-05-02 Reproductive Medicine And Gynaecology Associates Ltd Implant
PE20211195A1 (es) * 2017-09-27 2021-07-01 Bayer Oy Un metodo para modificar la liberacion de un agente terapeuticamente activo de una matriz elastomerica
US11571328B2 (en) 2018-04-09 2023-02-07 Medicines360 IUD insertion devices
US20200261258A1 (en) 2019-02-19 2020-08-20 Medicines360 Devices, systems, methods and kits for insertion and removal of iuds
WO2023230619A1 (en) * 2022-05-26 2023-11-30 Insigna Inc. Prevention of estrus in sow and ruminants
US11938140B2 (en) 2022-05-26 2024-03-26 Insigna Inc. Non-surgical prevention of boar taint and aggressive behavior

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US4244949A (en) * 1978-04-06 1981-01-13 The Population Council, Inc. Manufacture of long term contraceptive implant
CH657779A5 (de) * 1982-10-05 1986-09-30 Sandoz Ag Galenische zusammensetzungen enthaltend calcitonin.
US5011692A (en) * 1985-12-28 1991-04-30 Sumitomo Pharmaceuticals Company, Limited Sustained pulsewise release pharmaceutical preparation
IT8702928A0 (it) * 1987-07-22 1987-07-22 Alga Di Giudici Angelamaria & Friggitrice con cestello rotante secondo un asse orizzontale.
ATE86484T1 (de) * 1987-08-08 1993-03-15 Akzo Nv Kontrazeptives implantat.
US4846844A (en) * 1987-08-31 1989-07-11 Eli Lilly And Company Antimicrobial coated implants
JPH07216233A (ja) * 1992-09-21 1995-08-15 Toray Dow Corning Silicone Co Ltd フルオロシリコーンゴム組成物
US6117442A (en) * 1998-11-12 2000-09-12 Leiras Oy Drug delivery device, especially for the delivery of androgens

Also Published As

Publication number Publication date
BG65042B1 (bg) 2007-01-31
BR9915326B1 (pt) 2013-10-22
DK1128811T3 (da) 2004-09-27
HUP0104037A3 (en) 2003-04-28
KR20010075700A (ko) 2001-08-09
BR9915326A (pt) 2001-10-09
DE69917477T2 (de) 2005-06-02
ATE267004T1 (de) 2004-06-15
AU760302B2 (en) 2003-05-08
NZ511216A (en) 2002-09-27
EE200100256A (et) 2002-12-16
WO2000028968A1 (en) 2000-05-25
NO20012047L (no) 2001-06-28
CZ301609B6 (cs) 2010-04-28
PT1128811E (pt) 2004-09-30
HK1041814B (zh) 2005-04-29
BG105501A (en) 2001-12-29
US6063395A (en) 2000-05-16
IL142523A0 (en) 2002-03-10
AU1048800A (en) 2000-06-05
HK1041814A1 (en) 2002-07-26
RU2226387C2 (ru) 2004-04-10
ZA200103298B (en) 2001-10-25
SK286730B6 (sk) 2009-04-06
AR021152A1 (es) 2002-06-12
CA2351068C (en) 2008-09-02
SK5132001A3 (en) 2001-11-06
PE20001041A1 (es) 2000-10-14
CZ20011569A3 (cs) 2001-10-17
PL194876B1 (pl) 2007-07-31
CA2351068A1 (en) 2000-05-25
KR100621426B1 (ko) 2006-09-13
JP2002529493A (ja) 2002-09-10
ID29190A (id) 2001-08-09
DE69917477D1 (de) 2004-06-24
PL348113A1 (en) 2002-05-06
HUP0104037A2 (hu) 2002-04-29
CN1326337A (zh) 2001-12-12
HU226113B1 (en) 2008-04-28
CN1168439C (zh) 2004-09-29
EP1128811A1 (en) 2001-09-05
EP1128811B1 (en) 2004-05-19
NO332168B1 (no) 2012-07-09
IL142523A (en) 2006-06-11
ES2221454T3 (es) 2004-12-16
NO20012047D0 (no) 2001-04-26
CO5271704A1 (es) 2003-04-30

Similar Documents

Publication Publication Date Title
EE05506B1 (et) Ravimi manustamise vahend eriti progestiinide ja”strogeenide manustamiseks
ATE289500T1 (de) Ophtalmologische medikamentenzuführvorrichtung
DE69935681D1 (de) Vorrichtungen zur Medikamentverabreichung
DK1037667T3 (da) Farmaceutiske hydrogelformuleringer, lægemiddelindgivelsesanordninger samt fremgangsmåder
DK1473003T3 (da) Lægemiddeladministrationsanordning
DE60019949D1 (de) Arzneimittel enthaltendes system zur oralen abgabevorrichtung
EE05123B1 (et) Antiprogestiinsete omadustega ravimite manustamise vahendid
PT1221918E (pt) Administracao de drogas sub-tenon
AU6675198A (en) Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use
EP1036573A4 (en) DEVICE FOR ADMINISTERING A SUBSTANCE THROUGH THE SKIN OR A MUCUTINE
NO20014035D0 (no) System for oral administrasjon av medikament
IL127572A (en) Pharmaceutical composition and medicament for nasal administration
EE05415B1 (et) Ravimi manustamise vahend, eriti androgeenide manustamiseks
NO20026212D0 (no) Forbindelse for medikamentavleveringssystem og fremgangsmåte for fremstilling av forbindelsen
GB9809933D0 (en) Drug delivery device
AU2001258443A1 (en) Drug delivery device, especially for the delivery of gestodene
FR2796287B1 (fr) Dispositif d'administration de medicament
AU2001258442A1 (en) Drug delivery device, especially for the delivery of levonorgestrel
DE69914472D1 (de) Levosimendanhaltige oral anzuwendende arzneimittel mit gesteuerter wirkstoffverabreichung
IT1304899B1 (it) Metodo e dispositivo per la somministrazione di farmaci
ZA984649B (en) "Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes".
AUPQ552200A0 (en) Device and method for anterior segment drug delivery
DK0996436T3 (da) Farmaceutiske formuleringr, der indeholder tungtoplöselige lægemiddelstoffer
AUPP854499A0 (en) Device and method for anterior segment drug delivery
AUPP670198A0 (en) Drug delivery device

Legal Events

Date Code Title Description
HC1A Change of owner name
HC1A Change of owner name

Free format text: FORMER NAME: SCHERING OY

MM4A Lapsed by not paying the annual fees

Effective date: 20171026